Data Secrets to A Successful Drug Launch
Reltio
AUGUST 17, 2018
A new product’s commercial performance during the first six months after FDA approval is often considered a very important indicator for how the product will do over the course of its patent life. During this phase, there is often enormous pricing pressure from competitive products and health insurers.
70 
Let's personalize your content